SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Revolution Medicines Q3 Results Due November 4 After Close

Revolution Medicines is scheduled to report Q3'26 results after the market closes on November 4.

RVMD

RVMD (Revolution Medicines, Inc.) is set to announce its Q3'26 results on November 04, after the market closes. The earnings are expected to be disclosed at 4:02 PM ET (9:02 PM UTC).For Q3'26, revenue estimate is 25.58 million USD with EPS (earnings per share) anticipated at (2.35) USD. Learn more…

Related stories